News from advanced biologics A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 13, 2014, 08:30 ET

Advanced Biologics publishes additional OsteoAMP® data in Journal of Spine

Advanced Biologics announced today the acceptance for publication of a new OsteoAMP study to be published in the Journal of Spine.  In the...

Jul 24, 2014, 10:28 ET

Advanced Biologics publishes additional OsteoAMP® abstracts in The Bone and Joint Journal

Advanced Biologics, currently attending the NASS Summer Spine Meeting in Amelia Island, FL, announced today the publishing of two abstracts...

Apr 07, 2014, 08:15 ET

Advanced Biologics publishes OsteoAMP® cervical spine fusion results in Journal of Spine

 Advanced Biologics announced today that they will be showcasing their most recent peer-reviewed published data at the American Academy of...

Dec 30, 2013, 08:00 ET

Advanced Biologics' OsteoAMP® peer-reviewed study published demonstrating superior fusion results versus rhBMP-2

In the first head to head, peer reviewed, published study, patients undergoing LLIF/TLIF procedures with OsteoAMP showed higher fusion rates and...

Oct 10, 2013, 10:38 ET

Advanced Biologics presenting new OsteoAMP® data and delivery device at two global orthopaedic meetings

Advanced Biologics, developers and marketers of OsteoAMP® Allogeneic Morphogenetic Protein, announced today that it will be presenting new...

Sep 10, 2013, 08:45 ET

Advanced Biologics Opens New and Expanded Headquarters in Carlsbad, California

Advanced Biologics, developers and marketers of OsteoAMP® Allogeneic Morphogenetic Protein, is pleased to announce the expansion and...

Apr 29, 2013, 08:25 ET

Advanced Biologics adds more patient results showcasing OsteoAMP®'s Superior Fusion Rates Compared to rhBMP-2

Advanced Biologics announced today that they will be presenting expanded data at the American Academy of Neurosurgeons (AANS) meeting this week in...

Oct 25, 2012, 09:00 ET

Advanced Biologics Validates OsteoAMP® Process Demonstrating No Clinically Relevant 'Donor to Donor' Variation

 Advanced Biologics announced today that is has validated the OsteoAMP process showing no clinically relevant 'donor to donor' variation. ...

Oct 22, 2012, 08:30 ET

Advanced Biologics' OsteoAMP® Provides Additional Evidence of Superiority over rhBMP-2

Advanced Biologics announced today that they will be releasing data at the North American Spine Society (NASS) annual meeting this week in Dallas,...

Apr 16, 2012, 08:00 ET

Advanced Biologics' OsteoAMP® Shows Evidence of Superior Fusion Rates Compared to rhBMP-2

 Advanced Biologics announced today that they will be presenting data at the American Academy of Neurosurgeons (AANS) meeting this week in...

Apr 10, 2012, 09:00 ET

Advanced Biologics Awarded Supplier Agreement with Premier Healthcare Alliance for OsteoAMP® Product Line

 Advanced Biologics announced today that its OsteoAMP® product platform has been awarded a supplier contract with the Premier Healthcare...

Nov 02, 2011, 08:00 ET

Advanced Biologics Wins Best New Technology for Spine Care in 2011

Advanced Biologics, (www.advancedbiologics.com) announced today that OsteoAMP® Structural has been awarded with a "Best New Technology for...

Nov 01, 2011, 08:00 ET

Advanced Biologics Launches OsteoAMP® Structural at the 26th Annual Meeting of the North American Spine Society

 Advanced Biologics, (www.advancedbiologics.com) announced today that they will be launching the newest product within the OsteoAMP®...

Mar 30, 2005, 00:00 ET

Advanced Biological Laboratories SA (ABL, S.A) Licenses Stanford HIV Resistance Interpretation Algorithm - Adds to ViroScore Suite Genetic Sequence Database and Analysis Engine

TOPSFIELD, Mass., March 30 /PRNewswire/ -- ABL, SA (A Luxembourg Company) with TherapyEdge Inc. (Durham, NC) today announced it had signed a...

Feb 22, 2005, 00:00 ET

Advanced Biological Laboratories SA (ABL, SA) Acquires Majority Control of TherapyEdge Inc.; Acquisition Adds Key Biotech Patent and Related Products

DURHAM, N.C., Feb. 22 /PRNewswire/ -- ABL, SA (A Luxembourg Company) acquired majority control of TherapyEdge Inc.(Durham, NC) and its strategic...